Canland Health Corp. Applies for Temporary Exemption from Filing Its Quarterly Report for the Period Ended May 31, 2020 (Q1)

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

VANCOUVER, BC / ACCESSWIRE / August 4, 2020 / Canland Health Corp. (the “Company”), due to ongoing non-essential business shut down for COVID-19 measures taken by the Province of British Columbia, is relying on the exemption in BC Instrument 51-517 issued by the British Columbia Securities Commission and the reciprocating similar instrument issued by the Alberta Securities Commission allowing it to delay the filing of its interim financial statements, management discussion & analysis, and CEO & CFO certifications for the quarter ending May 31, 2020 (the “Filings”) as normally required under parts 4 and 5 of National Instrument 51-102 — Continuous Disclosure Obligations and Part 5 of National Instrument 52-109 – Certification of Disclosure in Issuers’ Annual and Interim Filings.

As required by BC Instrument 51-517, the Company provides the following updates and information for investors:

  • it is impractical, with the provincial shut down of non-essential business, to complete and file the quarterly financial statements as scheduled;

  • all Company executives and directors and insiders are subject to a trading black-out policy that reflects the principles in section 9 of National Policy 11-207

  • Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions until the quarterly financial statements are filed;

  • except as otherwise disclosed, no material business developments have occurred since filing of the Company’s interim financial statements for the period ended November 30, 2019;

  • management continues to seek viable business opportunities;

  • management estimates that it will be able to file the Filings by August 31, 2020; and

  • should material business developments occur, the Company will update shareholders accordingly.

About Canland Health Corp.

Canland Health Corp. is in the business of venture capital and investment in the Canadian healthcare sector.

For further information please contact:

Jacky Fu, CFO and director
E-mail: jfu@canlandhc.com

Forward-Looking Information: This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of the Company. Forward-looking information is based on certain key expectations and assumptions made by the management of the Company. Although the Company believes that the expectations and assumptions on which such forward-looking information is based on are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Forward-looking statements contained in this press release are made as of the date of this press release. The Company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

SOURCE: Canland Health Corp.

View source version on accesswire.com:
https://www.accesswire.com/600264/Canland-Health-Corp-Applies-for-Temporary-Exemption-from-Filing-Its-Quarterly-Report-for-the-Period-Ended-May-31-2020-Q1

Staff

Recent Posts

Assembly Biosciences Presents Data Highlighting Recurrent Genital Herpes Program at STI & HIV 2025 World Congress and International Herpesvirus Workshop

– Phase 1a clinical data in healthy participants presented for both ABI-5366 and ABI-1179, novel…

11 hours ago

ISS Recommends Shareholders Vote FOR the Merger between Regional Health Properties, Inc. and SunLink Health Systems, Inc.

Atlanta, GA., July 25, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCBQ: RHEP)…

11 hours ago

PharmAla Issues Q3 Financial Statements

TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…

11 hours ago

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”)…

11 hours ago

Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025

DOVER, Del., July 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”)…

11 hours ago

IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025

ORLANDO, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the…

11 hours ago